These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30285261)

  • 1. Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City.
    Walker JJ; Olsen ME
    South Med J; 2018 Oct; 111(10):575-578. PubMed ID: 30285261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in For-Profit Medication-Assisted Therapy Clinics in an Appalachian City.
    Holt HD; Olsen M
    South Med J; 2021 Feb; 114(2):70-72. PubMed ID: 33537785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
    Patrick SW; Buntin MB; Martin PR; Scott TA; Dupont W; Richards M; Cooper WO
    Subst Abus; 2019; 40(3):356-362. PubMed ID: 29949454
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
    Martin PR; Finlayson AJ
    Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine charges to uninsured patients at top-ranked U.S. hospitals.
    Niforatos JD; Dorner SC; Pescatore RM; Raja AS
    Am J Emerg Med; 2019 Dec; 37(12):2253-2254. PubMed ID: 31047741
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.
    Van Zee A; Fiellin DA
    Am J Public Health; 2019 Mar; 109(3):393-394. PubMed ID: 30726142
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.
    Roncero C; Domínguez-Hernández R; Díaz T; Fernández JM; Forcada R; Martínez JM; Seijo P; Terán A; Oyagüez I
    Adicciones; 2015 Sep; 27(3):179-89. PubMed ID: 26437312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Use Disorder in Pregnancy.
    Roper V; Cox KJ
    J Midwifery Womens Health; 2017 May; 62(3):329-340. PubMed ID: 28561914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.
    O'Connor AB; Kelly BK; O'Brien LM
    Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
    Mittal L; Suzuki J
    Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19.
    Lensch AC; Hairston E; Carter G; Jones HE
    J Addict Med; 2022 Jan-Feb 01; 16(1):e44-e47. PubMed ID: 33606424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-assisted treatment with buprenorphine: assessing the evidence.
    Thomas CP; Fullerton CA; Kim M; Montejano L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):158-70. PubMed ID: 24247147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to accessing opioid agonist therapy in pregnancy.
    Bedrick BS; O'Donnell C; Marx CM; Friedman H; Carter EB; Stout MJ; Kelly JC
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100225. PubMed ID: 33345932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with buprenorphine versus methadone use in pregnancy.
    Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
    Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.
    Winstock AR; Lea T; Ritter A
    Drug Alcohol Rev; 2007 Jul; 26(4):411-6. PubMed ID: 17564877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.